SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-013909
Filing Date
2018-11-07
Accepted
2018-11-07 17:11:17
Documents
65
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arbutusq32018.htm 10-Q 976861
2 EXHIBIT 3.1 exhibit31amendmenttoarticl.htm EX-3.1 33339
3 EXHIBIT 10.1 exhibit101execemploymentgp.htm EX-10.1 95319
4 EXHIBIT 31.1 exhibit311q32018.htm EX-31.1 13502
5 EXHIBIT 31.2 exhibit312q32018.htm EX-31.2 13976
6 EXHIBIT 32.1 exhibit321q32018.htm EX-32.1 6607
7 EXHIBIT 32.2 exhibit322q32018.htm EX-32.2 6903
14 pipelinea02.jpg GRAPHIC 119787
  Complete submission text file 0001628280-18-013909.txt   5080880

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT abus-20180930.xml EX-101.INS 842862
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20180930.xsd EX-101.SCH 42252
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20180930_cal.xml EX-101.CAL 77202
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20180930_def.xml EX-101.DEF 202929
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20180930_lab.xml EX-101.LAB 533783
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20180930_pre.xml EX-101.PRE 304742
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 181167308
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1